Jinyoung Kang

Jinyoung Kang is a Researcher at the McGovern Institute for Brain Research, Massachusetts Institute of Technology (MIT). Their work focuses on developing advanced nanotechnology-based tools for biomedical applications, particularly in neuroscience and regenerative medicine. Kang's research emphasizes nanoparticle engineering, expansion microscopy techniques, and targeted drug delivery systems to address challenges in brain disorders, cancer therapy, and tissue repair.

Key research interests include:

• Design of biocompatible porous silicon nanoparticles for therapeutic delivery
• Super-resolution imaging through expansion microscopy to visualize brain nanostructures
• Development of multifunctional nanomaterials for simultaneous diagnosis and treatment
• Optimization of drug release kinetics for targeted therapies

Publications from 2020-2024 highlight Kang's contributions to neuroimaging innovations, tumor-targeted therapies, and regenerative biomaterials. The research demonstrates a strong emphasis on translating nanotechnology into clinical applications for conditions like rheumatoid arthritis, traumatic brain injury, and ovarian cancer. While no specific awards are listed, their work reflects impactful contributions to the fields of nanomedicine and biomedical engineering.

Current affiliations include the McGovern Institute's neuroscience programs, with active collaborations in MIT's Department of Brain and Cognitive Sciences. No advising roles or grants are explicitly mentioned in the provided information.